EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study

Jae Eun Seong iD, Sang Min Ahn iD, Min Han iD, Yong Seop Lee iD, Jung Ah Lee iD, Jin Young Ahn iD, Su Jin Jeong iD, Nam Su Ku iD, Jun Yong Choi iD, Joon-Sup Yeom iD, Jung Ho Kim iD

Infection & Chemotherapy · 2026 · 58 (1) · 19

DOI: 10.3947/ic.2025.0070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection & Chemotherapy, 2026. Verfasst von Jae Eun Seong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Seoul Medical Center, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Anti-HIV agentsDolutegravirHIVLamivudine

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Seoul Medical Center, Seoul, Korea.
  • Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea. qetu1111@yuhs.ac.

ORCID-Profile: Jae Eun Seong, Sang Min Ahn, Min Han, Yong Seop Lee, Jung Ah Lee, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Jun Yong Choi, Joon-Sup Yeom, Jung Ho Kim

Zitieren

APA

Seong, J. E., Ahn, S. M., Han, M., Lee, Y. S., Lee, J. A., Ahn, J. Y., Jeong, S. J., Ku, N. S., Choi, J. Y., Yeom, J. S., & Kim, J. H. (2026). Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study. Infection & Chemotherapy, 58(1), 19. https://doi.org/10.3947/ic.2025.0070

Vancouver

Seong JE, Ahn SM, Han M, Lee YS, Lee JA, Ahn JY, et al. Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study. Infection & Chemotherapy. 2026;58(1):19. doi:10.3947/ic.2025.0070

BibTeX
@article{Seong2026,
  author = {Seong, Jae Eun and Ahn, Sang Min and Han, Min and Lee, Yong Seop and Lee, Jung Ah and Ahn, Jin Young and Jeong, Su Jin and Ku, Nam Su and Choi, Jun Yong and Yeom, Joon-Sup and Kim, Jung Ho},
  title = {Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study},
  journal = {Infection & Chemotherapy},
  year = {2026},
  volume = {58},
  number = {1},
  pages = {19},
  doi = {10.3947/ic.2025.0070}
}
Kostenlos starten →